Companies › ILMN
ILLUMINA INC (ILMN)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001110803 · EDGAR filings · Updated 2026-07-02
ILLUMINA INC (ILMN) has reported institutional ownership of 103.0%, with 838 institutional managers holding positions valued at $19.2B per the latest 13F reporting period.
Latest updates
- 2026-07-02 — Insider transaction reported (Form 4)
- 2026-07-02 — Insider transaction reported (Form 4)
- 2026-06-25 — Insider transaction reported (Form 4)
- 2026-06-25 — Notice of proposed sale filed (Form 144)
- 2026-06-25 — Notice of proposed sale filed (Form 144)
- 2026-06-23 — Insider transaction reported (Form 4)
- 2026-06-23 — Initial insider ownership filed (Form 3)
- 2026-06-23 — Current report (8-K) filed
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, ILLUMINA INC has 838 institutional holders and institutional ownership of 103.0%.
| # | Institution | Reported value | % of tracked total |
|---|---|---|---|
| 1 | BlackRock, Inc. | $2.34B | 12.2% |
| 2 | Capital World Investors | $1.92B | 10.0% |
| 3 | VANGUARD PORTFOLIO MANAGEMENT LLC | $841.1M | 4.4% |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | $812.9M | 4.2% |
| 5 | STATE STREET CORP | $792.5M | 4.1% |
| 6 | WCM INVESTMENT MANAGEMENT, LLC | $715.6M | 3.7% |
| 7 | AQR CAPITAL MANAGEMENT LLC | $490.7M | 2.6% |
| 8 | Corvex Management LP | $472.0M | 2.5% |
| 9 | Sessa Capital IM, L.P. | $403.8M | 2.1% |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | $375.1M | 2.0% |
Full holder history and quarter-over-quarter changes are available inside the app.
Insider activity
Insiders reported 72 transactions (10 buys, 4 sells) across 20 reporting insiders, with a net reported value of $1.03M.
Quarterly net insider value, as reported in Form 4 filings.
Fails-to-deliver
The SEC's fails-to-deliver file for 2026-06-29 reports 3,858 failed-to-deliver shares ($681.1K) for ILMN — an official data point published by the SEC, shown as reported.
Related companies
LABCORP HOLDINGS INC (LH) · GSK PLC (GSK) · QUEST DIAGNOSTICS INC (DGX) · REVOLUTION MEDICINES INC (RVMD) · INCYTE CORP (INCY) · ZIMMER BIOMET HLDGS INC (ZBH)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-02.